Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

MYGN – Myriad Genetics, Inc.

Myriad Genetics, Inc.
MYGN
$5.12
Name : Myriad Genetics, Inc.
Sector : Healthcare
Industry: Diagnostics & Research
Mark. Cap: $471,948,288.00
EPSttm : -1.12
finviz dynamic chart for MYGN
Myriad Genetics, Inc.
$5.12
4.07%
$0.2

Float Short %

9.03

Margin Of Safety %

Put/Call OI Ratio

0.07

EPS Next Q Diff

0.15

EPS Last/This Y

1.4

EPS This/Next Y

0.19

Price

4.92

Target Price

7.36

Analyst Recom

3.12

Performance Q

-53.23

Relative Volume

1.26

Beta

1.85

Ticker: MYGN




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-05-07MYGN4.270.110.432879
2025-05-08MYGN4.020.140.363516
2025-05-09MYGN3.90.130.433945
2025-05-12MYGN4.260.140.194111
2025-05-13MYGN4.110.141.004305
2025-05-14MYGN3.850.14201.004368
2025-05-15MYGN4.110.200.244649
2025-05-16MYGN4.160.170.084896
2025-05-19MYGN4.440.270.032613
2025-05-20MYGN4.460.270.002644
2025-05-21MYGN4.070.270.022660
2025-05-22MYGN3.930.260.132733
2025-05-23MYGN3.920.14999.994908
2025-05-27MYGN4.150.140.004899
2025-05-28MYGN4.320.140.004917
2025-05-29MYGN4.160.140.315007
2025-05-30MYGN4.210.140.005015
2025-06-02MYGN4.480.140.095018
2025-06-03MYGN4.890.130.005047
2025-06-04MYGN5.290.140.005040
2025-06-05MYGN4.910.070.419135
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-05-07MYGN4.27-443.9126.60.08
2025-05-08MYGN4.02-55.6129.90.08
2025-05-09MYGN3.89-55.6119.0-0.01
2025-05-12MYGN4.25-55.6118.8-0.01
2025-05-13MYGN4.11-114.6122.2-0.01
2025-05-14MYGN3.86-114.6122.2-0.01
2025-05-15MYGN4.11-114.6122.0-0.01
2025-05-16MYGN4.15-114.6122.1-0.01
2025-05-19MYGN4.43-114.6122.0-0.01
2025-05-20MYGN4.45-114.6122.1-0.01
2025-05-21MYGN4.07-114.6122.2-0.01
2025-05-22MYGN3.92-114.6122.2-0.01
2025-05-23MYGN3.91-114.6122.1-0.01
2025-05-27MYGN4.15-122.7122.0-0.01
2025-05-28MYGN4.32-122.7122.1-0.01
2025-05-29MYGN4.15-122.7122.2-0.01
2025-05-30MYGN4.19-122.7122.1-0.01
2025-06-02MYGN4.48-122.7122.0-0.01
2025-06-03MYGN4.88-122.7122.0-0.01
2025-06-04MYGN5.30-122.7122.0-0.01
2025-06-05MYGN4.92-122.7122.2-0.01
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-05-07MYGN0.001.105.85
2025-05-08MYGN0.001.105.85
2025-05-09MYGN0.001.105.85
2025-05-12MYGN0.00-0.476.37
2025-05-13MYGN0.00-0.476.37
2025-05-14MYGN0.00-0.476.37
2025-05-15MYGN0.00-0.476.37
2025-05-16MYGN0.00-0.476.37
2025-05-19MYGN0.000.276.37
2025-05-20MYGN0.000.276.37
2025-05-21MYGN0.000.276.37
2025-05-22MYGN0.000.276.37
2025-05-23MYGN0.000.276.37
2025-05-27MYGN0.000.116.37
2025-05-28MYGN0.000.119.03
2025-05-29MYGN0.000.119.03
2025-05-30MYGN0.000.119.03
2025-06-02MYGN0.001.439.03
2025-06-03MYGN0.001.439.03
2025-06-04MYGN0.001.439.03
2025-06-05MYGN0.001.439.03
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

-0.14

Avg. EPS Est. Current Quarter

-0.01

Avg. EPS Est. Next Quarter

0.01

Insider Transactions

Institutional Transactions

1.43

Beta

1.85

Average Sales Estimate Current Quarter

202

Average Sales Estimate Next Quarter

204

Fair Value

Quality Score

49

Growth Score

42

Sentiment Score

30

Actual DrawDown %

86.7

Max Drawdown 5-Year %

-89.5

Target Price

7.36

P/E

Forward P/E

32.1

PEG

P/S

0.55

P/B

0.64

P/Free Cash Flow

EPS

-1.12

Average EPS Est. Cur. Y​

-0.01

EPS Next Y. (Est.)

0.18

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-12.2

Relative Volume

1.26

Return on Equity vs Sector %

-38.4

Return on Equity vs Industry %

-25

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.08

EBIT Estimation

122.2
Myriad Genetics, Inc.
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 2700
Myriad Genetics, Inc., a molecular diagnostic testing and precision medicine company, develops and provides molecular tests in the United States and internationally. The company offers molecular diagnostic tests for oncology, women's health, and pharmacogenomics. It also provides MyRisk Hereditary Cancer test, a DNA sequencing test for assessing the risks for hereditary cancers; BRACAnalysis CDx Germline Companion Diagnostic test, a DNA sequencing test to help determine the therapy for metastatic breast, ovarian, metastatic pancreatic, and metastatic prostate cancer with deleterious or suspected deleterious germline BRCA variants; and MyChoice CDx Companion Diagnostic test, a tumor test that determines homologous recombination deficiency status in patients with ovarian cancer. In addition, the company offers Prolaris Prostate Cancer Prognostic test, an RNA expression tumor analysis for assessing the aggressiveness of prostate cancer; EndoPredict Breast Cancer Prognostic test, an RNA expression test for assessing the aggressiveness of breast cancer; Precise Tumor Molecular Profile test, a genomic profiling test; Prequel Prenatal Screen, a non-invasive prenatal screening test conducted using maternal blood to screen for severe chromosomal disorders in a fetus; Foresight Carrier Screen, a prenatal test for future parents to assess their risk of passing on a recessive genetic condition to their offspring; SneakPeek Early Gender DNA test, a non-invasive blood test that predicts the gender of a fetus; and GeneSight Psychotropic Mental Health Medication test, a DNA genotyping test to aid psychotropic drug selection for depression, anxiety, attention-deficit/hyperactivity disorder, and other mental health conditions. It has a license collaboration with Illumina, Inc.; Memorial Sloan Kettering Cancer Center; the University of Texas MD Anderson Cancer Center; the University of Rochester Medical Center; and Flatiron Health, Inc. The company was founded in 1991 and is headquartered in Salt Lake City, Utah.
stock quote shares MYGN – Myriad Genetics, Inc. Stock Price stock today
news today MYGN – Myriad Genetics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch MYGN – Myriad Genetics, Inc. yahoo finance google finance
stock history MYGN – Myriad Genetics, Inc. invest stock market
stock prices MYGN premarket after hours
ticker MYGN fair value insiders trading